In human patients with non-small cell lung cancer (NSCLC), TIM-3 is predominantly expressed in tumor-infiltrating CD4+ and CD8+ T cells, but expressed at minimal levels on T cells from peripheral blood. The gene discussed is HAVCR2; the disease is non-small cell lung carcinoma.